09.22.2022

SonoMotion receives FDA Breakthrough Device Designation for Break Wave™ procedure.

08.15.2022

Sonomotion raises USD$12.4 Million in Series C funding to advance development of Break Wave™. Round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.